Delivering value with a Strategic Rx
“As part of our regular review of assets, it became clear that our strong specialty pharmacy business unit will better meet its full potential outside of our business. We are confident this transaction will help the business to grow and deliver better results for patients.”
Colleen Lindholz
President
Kroger Health
Delivering
value creation
Kroger, one of the largest retail grocery chains in the United States, has operated Kroger Specialty Pharmacy since 2012, serving patients with chronic illnesses requiring complex care.
Kroger made the decision to sell its specialty pharmacy business to CarelonRx, an Elevance Health company, in a $464M transaction. This divestiture enables Kroger to focus on its leading grocery retail and in-store pharmacy and healthcare offerings.
RBC effectively navigated the intersection of the consumer and healthcare industries to help identify the right strategic buyers for Kroger, delivering an optimal outcome for all. For Elevance Health, the acquisition strengthens its ability to deliver high-quality, convenient specialty pharmacy services—a critical component of its expanding healthcare platform.
RBC Capital Markets acted as Kroger’s exclusive financial advisor on the transaction.
Accelerating
strategic support
The specialty pharmacy sector is poised for continued growth, fueled by a robust pipeline of innovative drugs, a high-need patient population, and a shifting distribution landscape that awards exclusive rights to fewer pharmacies. Recognizing the ongoing consolidation and evolution of the sector—where few large, independent assets remain—RBC Capital Markets leveraged its deep cross-sector knowledge and healthcare investment banking expertise to position Kroger’s specialty pharmacy business as a strategic opportunity to maximize shareholder value.
While a healthcare buyer was initially considered the most likely acquirer, Kroger’s specialty pharmacy business attracted bidders looking to capitalize on industry tailwinds for accelerated growth and profitability. Recognizing that the right buyer must integrate the asset into a broader, vertically integrated operation, RBC identified the asset's strong alignment with Elevance’s strategic priorities and the significant potential for value creation.
Due to the dynamic nature of the sector, RBC proactively managed an accelerated deal timeline, facilitating an efficient deal closure. The transaction reflects RBC Capital Markets’ longstanding partnership with Kroger, led by Douglas Trauber, Global Head of Consumer & Retail Investment Banking, who has built a 20-year relationship with the company.
A rare, high-scale strategic asset
Kroger’s specialty pharmacy business represented a rare, high-scale asset in a highly complex and rapidly evolving sector. As one of the few independent assets of this size, it was a strategic chess piece in the market—driving strong interest from buyers looking to expand their footprint in specialty pharmacy.
Cross-sector expertise: Consumer and Healthcare banking leadership
RBC’s deep cross-sector expertise provided a distinct advantage in executing this transaction. With a strong track record in Consumer and Healthcare investment banking, RBC effectively navigated the intersection of these industries—identifying the right strategic buyers, and delivering an optimal outcome for all stakeholders.
Executing
for success
Renewed M&A momentum, underpinned by stable valuations and innovative business models driving operational evolution, positions specialty pharma for sustained growth and ongoing market relevance.
For Elevance Health, the acquisition strengthens its commitment to investing in high-growth healthcare sectors. With a history of strategic acquisitions and deep expertise in specialty pharma, Elevance Health is ensured throughout the transition there was minimal disruption to patients, employees, or the ongoing operation of Kroger specialty pharmacies—ensuring continuity of care while enabling both companies to focus on their long-term growth strategies.